Cargando…
Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
BACKGROUND: Feline mammary carcinoma has been proposed as a natural model of highly aggressive, hormone-independent human breast cancer. To further explore the utility of the model by adding new similarities between the two diseases, we have analyzed the oncogene HER-2 status at both the protein and...
Autores principales: | Ordás, Javier, Millán, Yolanda, Dios, Rafaela, Reymundo, Carlos, Martín de las Mulas, Juana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2045669/ https://www.ncbi.nlm.nih.gov/pubmed/17880730 http://dx.doi.org/10.1186/1471-2407-7-179 |
Ejemplares similares
-
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
por: Maniscalco, Lorella, et al.
Publicado: (2013) -
The human intermediate prolactin receptor is a mammary proto-oncogene
por: Grible, Jacqueline M., et al.
Publicado: (2021) -
HER2-positive feline mammary carcinoma
por: Marques, Cláudia, et al.
Publicado: (2016) -
Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue
por: Magi, Gian Enrico, et al.
Publicado: (2022) -
Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization
por: Baek, Kwang Hyun, et al.
Publicado: (2012)